Novel molecular approaches for understanding the epidemiology of endemic anthrax
Novel molecular approaches for understanding the epidemiology of endemic anthrax
批准号:
BB/R012075/1
负责人:
Taya Forde
金额:
$38.63万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2018
资助国家:
英国
项目状态:
已结题
起止时间:
2018 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project will study anthrax, a bacterial disease of people and animals, in developing-country settings where the disease is widespread. While anthrax is most commonly known as an agent of bio-terrorism, it in fact remains a common disease in many poor rural areas, particularly in sub-Saharan Africa. It primarily affects ruminant livestock and wildlife, wherein the disease manifests as sudden deaths. The bacterial spores that cause anthrax can also secondarily infect humans. Anthrax can take one of three forms in people, depending on the route of transmission: a less serious from causing skin lesions, and two more severe forms affecting the digestive and respiratory systems. All three forms can be fatal if left untreated. The greatest impacts of this disease are felt by livestock-keeping communities, where animal losses represent significant costs for livelihoods and food security, and result in risk of human exposure.This project will be based in the Ngorongoro Conservation Area in Tanzania, East Africa. This area - rich in a variety of wildlife - is home to Maasai pastoralists who depend almost entirely on livestock for food and income. Anthrax is a major issue for both animal and human health in this area. Livestock losses occur regularly, with approximately a quarter of households reporting suspected cases in their herds over the past two years. Additionally, more than 40 cases of human anthrax - including five deaths - were seen at the regional hospital in the second half of 2016 alone. In this unique study system, I will apply novel techniques to study the genetic characteristics of bacteria obtained from affected animals and people. These analyses will allow me to determine the main sources of infection for animals and people, and how these cases are linked.The main objective of this study is to determine how the bacterium that causes anthrax is spread and transmitted, particularly during outbreaks. This includes assessing how often transmission occurs between different host species, and identifying the main sources of risk for livestock and people. I will train a team of local human and animal health professionals to conduct in-depth case investigations. The team will collect detailed data and samples during outbreaks. This training will contribute not only to the project, but will strengthen local capacity to handle this and other animal diseases. To ensure that affected community members, health practitioners, and local and national policy makers are involved at all stages of the research, I will invite representatives from these groups to attend annual workshops that I will host. These will maximise the benefits of my research by increasing disease awareness, improving connectivity among key individuals in the community and government, and ensuring that project results are able to feed directly into policy.The samples collected from the different host species during this project will serve as a source of bacterial DNA that can be used to track transmission, similarly to DNA fingerprinting in forensics investigations. The DNA from these various sources (e.g. livestock, wildlife and people) will be fully analysed to obtain the genome of each individual bacterium. These data will provide incredibly high-resolution information that will allow me to reconstruct chains of transmission amongst affected species, determine associations between particular strains and different host species, and understand whether individual cases may be the result of infection from multiple sources.I will use the novel information generated by my study to provide management and control recommendations for anthrax in rural livestock-keeping communities, leading to enhanced animal and human health, and improved food security and poverty alleviation through reduced production losses.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41598-022-14081-5
发表时间:
2022-06-22
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Aminu, Olubunmi R., Forde, Taya L., Ekwem, Divine, Johnson, Paul, Nelli, Luca, Mmbaga, Blandina T., Mshanga, Deogratius, Shand, Mike, Shirima, Gabriel, Walsh, Markus, Zadoks, Ruth N., Biek, Roman, Lembo, Tiziana]
通讯作者:
Lembo, Tiziana
DOI:
10.1099/mgen.0.000759
发表时间:
2022-03
期刊:
Microbial genomics
影响因子:
3.9
作者:
[Forde TL, Dennis TPW, Aminu OR, Harvey WT, Hassim A, Kiwelu I, Medvecky M, Mshanga D, Van Heerden H, Vogel A, Zadoks RN, Mmbaga BT, Lembo T, Biek R]
通讯作者:
Biek R
Emerging zoonoses in wildlife: understanding the ecology, transmission and impacts of Brucella and Erysipelothrix for conservation and food security
-
批准号:NE/X002616/1
-
项目类别:Research Grant
-
资助金额:$79.93万
-
财政年份:2022
-
负责人:Taya Forde
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: